Diagnosis and treatment of cholangiocarcinoma: A consensus from surgical specialists of China

References

[1] BismuthHCD. . Hepatobiliary malignancy, 1994, London, Edward Arnold

[2] O’GradyJG. Treatment options for other hepatic malignancies. Liver Transpl, 2000, 6(6suppl2): S23-S29

[3] de GroenPC, GoresGJ, LaRussoNF, et al.. Biliary tract cancers. N Engl J Med, 1999, 341(18): 1368-1378

[4] Taylor-RobinsonSD, ToledanoMB, AroraS, et al.. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut, 2001, 48(6): 816-820

[5] ChapmanRW. Risk factors for biliary tract carcinogenesis. Ann Oncol, 1999, 10Suppl4: 308-311

[6] RamageJK, DonaghyA, FarrantJM, et al.. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology, 1995, 108(3): 865-869

[7] PatelAH, HarnoisDM, KleeGG, et al.. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol, 2000, 95(1): 204-207

[8] HultcrantzR, OlssonR, DanielssonA, et al.. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol, 1999, 30(4): 669-673

[9] GoresGJ. Early detection and treatment of cholangiocarcinoma. Liver Transpl, 2000, 6(6Suppl): S30-S34

[10] KuszykBS, SoyerP, BluemkeDA, et al.. Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging. Crit Rev Diagn Imaging, 1997, 38(1): 59-88

[11] FulcherAS, TurnerMA. HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma. AJR Am J Roentgenol, 1997, 169(6): 1501-1505

[12] CieszanowskiA, ChomickaD, AndrzejewskaM, et al.. Imaging techniques in patients with biliary obstruction. Med Sci Monit, 2000, 6(6): 1197-1202

[13] FiguerasJ, LladoL, VallsC, et al.. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl, 2000, 6(6): 786-794

[14] YehTS, JanYY, TsengJH, et al.. Malignant perihilar biliary obstruction: magnetic resonance cholangiopanczreatographic findings. Am J Gastroenterol, 2000, 95(2): 432-440

[15] ZidiSH, PratF, Le GuenO, et al.. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut, 2000, 46(1): 103-106

[16] MagnusonTH, BenderJS, DuncanMD, et al.. Utility of magnetic resonance cholangiography in the evaluation of biliary obstruction. J Am Coll Surg, 1999, 189(1): 63-71

[17] WiersemaMJ, VilmannP, GiovanniniM, et al.. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology, 1997, 112(4): 1087-1095

[18] KlugeR, SchmidtF, CacaK, et al.. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology, 2001, 33(5): 1029-1035

[19] OguraY, TakahashiK, TabataM, et al.. Clinicopathological study on carcinoma of the extrahepatic bile duct with special focus on cancer invasion on the surgical margins. World J Surg, 1994, 18(5): 778-784

[20] HensonDE, Albores-SaavedraJ, CorleD. Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates. Cancer, 1992, 70(6): 1498-1501

[21] TorzilliG, MinagawaM, TakayamaT, et al.. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology, 1999, 30(4): 889-893

[22] RosenCB, Darwish MuradS, HeimbachJK, et al.. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?. J Am Coll Surg, 2012, 215(1): 31-38

[23] LaurentA, TayarC, CherquiD. Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford), 2008, 10(2): 126-129

[24] HejnaM, PruckmayerM, RadererM. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer, 1998, 34(7): 977-986

[25] BowlingTE, GalbraithSM, HatfieldAR, et al.. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut, 1996, 39(6): 852-855

[26] FooML, GundersonLL, BenderCE, et al.. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys, 1997, 39(4): 929-935